Therapies
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 2.1 | Q3 | 32.9% | 0.557 | Q3 | 65.0% |
| 2024 | 1.8 | Q3 | 31.2% | 0.432 | Q3 | 57.3% |
| 2023 | 2.2 | Q3 | 44.3% | 0.456 | Q3 | 61.9% |
| 2022 | 2.6 | Q3 | 44.3% | 0.540 | Q2 | 68.7% |
| 2021 | 3.4 | Q3 | 57.1% | 0.442 | Q3 | 63.3% |
| 2020 | — | — | 0.387 | Q3 | 58.3% | |
| 2019 | — | — | 0.352 | Q3 | 57.3% | |
| 2018 | — | — | 0.351 | Q3 | 54.8% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1958-5578
ISSN
0040-5957
country
FRcoverage
1947-1948, 1950-2026